Outlook Therapeutics Files 8-K
Ticker: OTLK · Form: 8-K · Filed: Nov 3, 2025 · CIK: 1649989
| Field | Detail |
|---|---|
| Company | Outlook Therapeutics, Inc. (OTLK) |
| Form Type | 8-K |
| Filed Date | Nov 3, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-event, filing, financials
TL;DR
OTLK filed an 8-K on Nov 3, 2025, covering other events and financials.
AI Summary
Outlook Therapeutics, Inc. filed an 8-K on November 3, 2025, reporting other events and financial statements. The company, formerly known as Oncobiologics, Inc. until August 4, 2015, is incorporated in Delaware and headquartered in Iselin, New Jersey.
Why It Matters
This filing provides an update on the company's corporate events and financial status, which is crucial for investors to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically reports significant events but doesn't inherently introduce new risks.
Key Players & Entities
- Outlook Therapeutics, Inc. (company) — Registrant
- November 3, 2025 (date) — Date of earliest event reported
- Oncobiologics, Inc. (company) — Former company name
- August 4, 2015 (date) — Date of name change
- Delaware (jurisdiction) — State of incorporation
- Iselin, New Jersey (location) — Principal executive offices
- 001-37759 (identifier) — Commission File Number
- 38-3982704 (identifier) — IRS Employer Identification No.
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' for Outlook Therapeutics, Inc.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on November 3, 2025.
What was Outlook Therapeutics, Inc. previously named?
Outlook Therapeutics, Inc. was formerly known as Oncobiologics, Inc.
On what date did the company change its name from Oncobiologics, Inc.?
The company changed its name from Oncobiologics, Inc. on August 4, 2015.
Where are Outlook Therapeutics, Inc.'s principal executive offices located?
Outlook Therapeutics, Inc.'s principal executive offices are located at 111 S. Wood Avenue, Unit #100, Iselin, New Jersey 08830.
Filing Stats: 421 words · 2 min read · ~1 pages · Grade level 10 · Accepted 2025-11-03 17:01:16
Filing Documents
- tm2530088d1_8k.htm (8-K) — 24KB
- tm2530088d1_ex99-1.htm (EX-99.1) — 11KB
- 0001104659-25-105633.txt ( ) — 201KB
- otlk-20251103.xsd (EX-101.SCH) — 3KB
- otlk-20251103_lab.xml (EX-101.LAB) — 33KB
- otlk-20251103_pre.xml (EX-101.PRE) — 22KB
- tm2530088d1_8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated November 3, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Outlook Therapeutics, Inc. Date: November 3, 2025 By: /s/ Lawrence A. Kenyon Lawrence A. Kenyon Chief Financial Officer